Clinical Trial Update: Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating cyclophosphamide and fludarabine followed by interleukin-2 gene-modified tumor-infiltrating lymphocytes in metastatic melanoma has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Interleukin-2 gene-modified tumor infiltrating lymphocytes

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Melanoma (Skin) | Phase 1, Phase 2 | Status: COMPLETED